Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Apr 1.
Published in final edited form as: Int J Drug Policy. 2024 Mar 14;126:104380. doi: 10.1016/j.drugpo.2024.104380

Punitive legal responses to prenatal drug use in the United States: A survey of state policies and systematic review of their public health impacts

Emilie Bruzelius a, Kristen Underhill b, Melanie S Askari a, Sandhya Kajeepeta a, Lisa Bates a, Seth J Prins a, Marian Jarlenski c, Silvia S Martins a
PMCID: PMC11056296  NIHMSID: NIHMS1977196  PMID: 38484529

Abstract

Background:

Punitive legal responses to prenatal drug use may be associated with unintended adverse health consequences. However, in a rapidly shifting policy climate, current information has not been summarized. We conducted a survey of U.S. state policies that utilize criminal or civil legal system penalties to address prenatal drug use. We then systematically identified empirical studies evaluating these policies and summarized their potential public health impacts.

Methods:

Using existing databases and original statutory research, we surveyed current U.S. state-level prenatal drug use policies authorizing explicit criminalization, involuntary commitment, civil child abuse substantiation, and parental rights termination. Next, we systematically identified quantitative associations between these policies and health outcomes, restricting to U.S.-based peer-reviewed research, published January 2000-December 2022. Results described study characteristics and synthesized the evidence on health-related harms and benefits associated with punitive policies. Validity threats were described narratively.

Results:

By 2022, two states had adopted policies explicitly authorizing criminal prosecution, and five states allowed pregnancy-specific and drug use-related involuntary civil commitment. Prenatal drug use was grounds for substantiating civil child abuse and terminating parental rights in 22 and five states, respectively. Of the 16 review-identified articles, most evaluated associations between punitive policies generally (k=12), or civil child abuse policies specifically (k=2), and multiple outcomes, including drug treatment utilization (k=6), maltreatment reporting and foster care entry (k=5), neonatal drug withdrawal syndrome (NDWS, k=4) and other pregnancy and birth-related outcomes (k=3). Most included studies reported null associations or suggested increases in adverse outcome following punitive policy adoption.

Conclusions:

Nearly half of U.S. states have adopted policies that respond to prenatal drug use with legal system penalties. While additional research is needed to clarify whether such approaches engender overt health harms, current evidence indicates that punitive policies are not associated with public health benefits, and therefore constitute ineffective policy.

Keywords: Prenatal substance use, Policy analysis, Drug treatment, Neonatal drug withdrawal syndrome

Background

In 2022, approximately one in five pregnant people in the United States (U.S.) reported engaging in some form of substance use, most commonly tobacco (5.5%), alcohol (11.0%) and prescription or nonprescription drugs including cannabis (9.6%).1 While the use of tobacco during pregnancy has generally not been subject to regulation, state and federal governments are increasingly addressing other forms of prenatal substance use, including the use of alcohol and other prescription or nonprescription drugs, especially opioids and amphetamines.2,3 Legislatures in many states have established prenatal substance use laws with the stated or implied purpose of reducing potential harms associated with substance use in pregnancy.4 For example, existing policies cite increases in drug treatment utilization or decreases in neonatal drug withdrawal syndrome (NDWS) as intended goals of legislation.5

While the overall number of states with any prenatal policy has rapidly accelerated in the past decade,3 states vary in the specific legal mechanisms they employ to reduce drug use. Punitive policies, which are generally consistent with criminal-legal system priorities, use coercive threats of criminal sanctions, custody loss, fines, and other penalties as presumed deterrents to substance use. In contrast, supportive policies are generally consistent with public health priorities, and typically promote prevention, treatment, or harm reduction goals, without penalties for nonadherence.

There is considerable concern from within legal, medical and public health communities that contrary to stated intent, punitive prenatal drug policies might increase potential harms.6-24 Evidence has repeatedly shown that health interventions founded on deterrence principles—the idea that punishments deter crimes—often lead to unintended adverse consequences as illegal behaviors are driven underground.25 Punitive policy critics stress that such approaches undermine pregnant people’s rights and patient-provider relationships by tasking health and social service providers with surveillance and punishment activities. Policies with punitive consequences may also discourage aspects of healthcare-seeking like prenatal care, that are critical to ensuing healthy pregnancies. Moreover, given substantial evidence that policy enforcement activities disproportionately target pregnant people of color and lower income people, punitive approaches have the potential to exacerbate existing inequities.16,26-31

Despite potential for adverse consequences—and evidence that states are becoming increasingly punitive over time—3,32,33 the empirical evidence evaluating punitive prenatal drug policies has not been summarized. Further, while several analyses document the evolution of policies through 2016,3,17 the present status of legislation remains under-characterized in a rapidly shifting policy climate. We therefore bridge this gap and summarize what is known about the status and effectiveness of punitive policies with a legal survey and systematic literature review. Specifically, we sought to identify state policies that impose criminal or custody-related penalties (e.g., civil child abuse, parental rights termination), or that authorize involuntary commitment in response to prenatal drug use. In addition, we sought to assess the corresponding evidence on policy-related health effects, specifically in terms of drug treatment, pregnancy and birth-related outcomes, NDWS, and child maltreatment reporting and foster care entry.

Methods

This review followed Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, and the literature review, but not the legal survey, was pre-registered in Prospero (CRD42022303040). For both the legal and literature portions, the review process consisted of 3 phases: identification and initial screening, full-text inclusion screening, and data extraction. Stage-specific inclusion and exclusion criteria are described in Figure 1.

Figure 1.

Figure 1.

Flow diagram for legal survey and systematic literature review. For the literature review, study design and article type exclusions included studies that did not report a quantitative outcome (e.g., qualitative analyses), or that were not published in a peer-reviewed journal. Studies excluded based on exposure status did not assess punitive policies directly targeting pregnant people (e.g., supportive policies). Other study exclusions occurred when the study did not include a U.S. population or were not published in English. The other exclusion category also included two studies reporting legal outcomes. Excluded studies may have met multiple exclusion criteria

Legal review

We updated previous reviews of policies governing prenatal drug use, documented heterogeneity, and incorporated legislation adopted after 2016.3,17,34 The timeframe was selected to extend existing legal reviews given recent policy shifts.3,35 Specifically in 2016, the federal child abuse law—the Child Abuse Prevention and Treatment Act (CAPTA)—was amended to require that states institute care planning and notification policies for infants identified as affected by prenatal substance exposure.36-38

Our inclusion criteria restricted searches to policies that explicitly allow criminal charges for prenatal drug use, authorize involuntary commitment, or impose civil penalties with custody-related repercussions (Table 1). We excluded polices that do not target pregnant people directly, such as mandatory reporting policies which require health and social service providers to report prenatal drug use to state authorities. We similarly excluded policies that target the romantic partners of pregnant people, or that only apply to businesses or other entities like social service agencies.34,39 For criminal policies, we specifically searched for enacted statutes but also considered states to have adopted criminalization based on judicial interpretation—here defined as a state supreme court decision. Policies associated with custody loss included those that classify prenatal drug use as civil child abuse, or that specify prenatal drug use as grounds for child abuse substantiation or parental rights termination. We excluded policies that mentioned parental drug use but did not clearly specify prenatal use as a criterion for enforcing penalties. For each policy, we additionally identified whether evidence of symptomology or harm was required (versus exposure only), whether exceptions for drug treatment were included, or whether other special circumstances were noted.

Table 1.

Policy definitions

Category Definition
Explicit criminalization Policies including judicial rulings that formally authorize criminal charges for prenatal drug use.
Involuntary commitment Policies that authorize pregnant women to be involuntarily committed when the courts determine that drug use poses a danger to the pregnancy.
Civil child abuse definitions Policies that include prenatal drug use in child abuse definitions or that consider prenatal drug use sufficient grounds for child abuse or neglect substantiation.
Parental rights termination Policies that consider prenatal drug use grounds for involuntary termination of parental rights.

We obtained legal data from two sources. First, we identified legal citations from existing datasets including the Alcohol Policy Information System (APIS), the Guttmacher Institute Prenatal Substance Use Policies dataset, the Child Welfare Information Gateway State Statute Database and previously published studies.3,35,40,41 From this corpus, we identified the most common terms related to prenatal substance use, then used terms to search LexisNexis for additional legislation (Supplemental Table 1). Because our focus was on current policies, we did not necessarily capture all repealed policies, but noted them when identified. After deduplication, we reviewed the text of collected statutes for inclusion. Lastly we abstracted relevant information based on themes identified from prior literature34 and questions that arose during the corresponding literature review.

Literature review

For the literature review, we identified studies estimating associations between punitive prenatal drug policies and health-related outcomes, published January 2000 to December 2022. This window was selected to include the period when punitive policy enactment began to escalate in response to increasing prenatal substance use, thus allowing for empirical investigations.3,26,42,43 Studies with any research design were included if they reported a quantitative association between a punitive policy and any potentially relevant health outcome, including in the context of mixed methods designs. Other than specifying quantitative research, we did not impose other restrictions on study design. Commentaries, dissertations, and other non-peer reviewed articles were excluded, as were studies that did not include a U.S. population.

To identify studies meeting these criteria, we searched EBSCOhost, Embase, ProQuest, PubMed, Scopus, and Web of Science using prespecified search terms (Supplemental Table 1) and exported results to Covidence for review. After deduplication, studies were screened on title and abstract, then relevant papers went through full text review. For each included study, we extracted article features, methods, and results.

We assessed potential validity threats using prespecified criteria based on methodological considerations relevant to policy evaluation (Supplemental Table 2).44-51 Focal areas included: study design and timeframe, exposure and outcome definitions, adjustment for time-varying confounders and co-occurring policies, and methods to account for baseline and time-varying differences between locations and over time, if applicable. For study design, we identified whether analyses were cross-sectional or longitudinal by level of analysis, and if a comparison group was included. For example, studies were considered to have a longitudinal comparison group design if they utilized a difference-in-differences, event-study, or synthetic control approach.52 Strengths and weaknesses across these domains were described narratively.

Each phase of the review processes was completed by two independent reviewers with disagreements resolved by discussion and consensus. Legal review content was presented to a third reviewer with expertise in prenatal substance use policy for additional validation. Initial legal and literature searches began in January 2022 and findings are current as of December 2022.

Results

Legal survey

The legal search identified 567 unique citations (Figure 1). In total, 131 statutes met criteria and were included. By 2022, approximately half of states had at least one punitive prenatal drug policy (n=25, Figure 2). The most common were those designating prenatal drug use as civil child abuse (n=23). Explicit criminalization (n=2), involuntary commitment (n=5) and parental rights termination (n=6) were less common. Geographic variation was noted, with criminalization limited to Southern states and involuntary commitment prevalent in the Midwest.

Figure 2.

Figure 2.

Distribution of punitive prenatal drug laws and policies across U.S. States, 2022

*Tennessee had a criminal law prohibiting prenatal use of non-prescription narcotics use between 2014 and 2016

Criminalization and involuntary commitment

South Carolina, Alabama, and Tennessee have each formally criminalized prenatal drug use. Tennessee’s policy has not been in effect since mid-2016 after expiring due to a sunset provision.26,53 Tennessee is the only state to have enacted a criminal policy via the legislature; criminalization in South Carolina and Alabama occurred first via court decisions, then later amendments in Alabama. In Tennessee, the legislature passed Fetal Assault as an amendment to the state’s existing fetal homicide policy. The change allowed prosecutors to charge pregnant people with misdemeanor assault following diagnosis of NDWS or evidence of prenatal use of an illegal drug. In South Carolina and Alabama, state supreme courts interpreted the term ‘child’ to include fertilized eggs or fetuses, thereby allowing legal grounds for felony or misdemeanor child abuse prosecutions for any type of prenatal drug use. The Alabama policy was initially geared specifically towards methamphetamine.54 Even though remaining states have not adopted policies explicitly authorizing criminalization, it should be noted that prenatal drug use is frequently charged under existing criminal statutes—for example pregnant people who experience stillbirth being charged with murder. Therefore, even in the absence of an overt criminal policy, individuals could be criminally prosecuted in other states and existing legal literature suggests that this practice is relatively common.26

In addition to criminal approaches, five states (MN, ND, OK, SD, WI) have policies that allow pregnant people to be held in physical custody or involuntarily committed to treatment for reasons related to prenatal drug use. In North Dakota, the mandatory reporting statute grants the state authority to act under the state’s involuntary commitment policy during pregnancy. In the remaining 4 states, protection of an ‘unborn child’ is explicitly cited as grounds for detention directly within the language of the involuntary commitment statute.

Custody-related penalties

Custody-related penalties were the most prevalent punitive policy observed, with policies in 23 and 6 states clearly considering prenatal drug use sufficient grounds for child abuse substantiation or parental rights termination (FL, IL, KY, MO, ND, TX, Figure 2). Several other states had policies that could arguably include prenatal drug use under child abuse statutes, however the text was ambiguous. For example, in Kentucky, the definition of child abuse includes parental incapacity due to substance use disorder, but does not cite prenatal exposure as a condition for enforcement.

We identified significant heterogeneity across state policies. For example, parental rights termination in Illinois and Missouri (but not FL, ND, and TX), is authorized only after a substance-exposed infant was previously born to the same person. Similarly, some states require evidence of infant symptomatology or NDWS before applying penalties. In most states, however, neonatal exposure alone—typically established via toxicology—is sufficient to trigger penalties. State policies also vary in terms of the substances and circumstances covered under punitive provisions. Most policies (n=18) included language to exclude medical treatments or legally prescribed medications from prenatal drug use definitions (Supplemental Table 3). In some instances, such language could be interpreted to carve out allowances for MOUD, but only one state policy (TN) appears to explicitly state this exception.

Literature review

The literature search identified 241 unique citations, 119 of which underwent full text review, resulting in 16 included articles. Search strategy and inclusion decision details are provided in Table 1 and Figure 1.

Twelve studies grouped policies dichotomously, with eight of these defining exposure using a combined measure capturing presence or absence of any policy (Table 2). The most frequent were criminal and civil child abuse. Relatively fewer studies included civil commitment (k=2)40,55 or parental rights termination (k=2) in operationalizations of punitive definitions.41,56 Six studies examined the impacts of individual policies in primary57,58 or sensitivity analyses,56 often using single-state analyses.53,59,60 Although most studies utilized the same exposure data source—the Guttmacher Institute Prenatal Substance Use Policy dataset—legal dates were sometimes conflicting, as has been noted previously.41,41,61,62

Table 2.

Characteristics of studies evaluating prenatal drug policies (k=16)

Time-
frame
Primary
study design
Outcomes
assessed
Outcome
data sources
Policy exposures
assessed
Exposure
data sources
assessed
Effect
measure
modifiers
Control for
co-occurring
policies
Control for state
differences, time
trends and
covariates
Angelotta 2016
2012 Cross-sectional data with comparison group Planned MOUD receipt TEDS-A Binary composite: criminal or civil child abuse Guttmacher Medicaid coverage of MOUD Geographical region; principal source of referral
Austin 2022
2006-2019 Cross-sectional data with comparison group Prenatal care initiation; prenatal care adequacy; postpartum care PRAMS (23 states) Categorical composite: (child abuse only, reporting only, both, neither) Original legal research Medicaid eligibility; Medicaid expansion; Medicaid Family Planning expansion; priority access to treatment; targeted treatment programs; cannabis legalization; obstetricians and gynecologists PC Linear time trend; state (GEE design); age; race and ethnicity; household income, education; mental health; experiences of violence; pregnancy intention
Atkins & Durrance 2020
2000-2014 Longitudinal data with comparison group NDWS (prevalence); Maternal narcotic exposure (prevalence); Treatment admissions among pregnant women out of admissions of reproductive age women (proportion) HCUP SIDS (37 states); TEDS-A Binary single polocy:civil child abuse Guttmacher Priority access to treatment for pregnant women; reporting/testing State and year fixed effects; % Black; median household income; % Medicaid coverage; unemployment rate
Atkins & Durrance 2021
2000-2016 Longitudinal data with comparison group Infant (<1yr) foster care entries; Infant (<1yr) foster care entries citing parental drug use or neglect AFCARS Binary single policy: civil child abuse Guttmacher Priority access to treatment for pregnant women; reporting/testing; PDMP State and year fixed effects; % Black; % Hispanic; median household income; % poverty; unemployment rate
Bandara 2022
2010-2017 Longitudinal data with comparison group (quantitative) and mixed methods qualitative Infant (<1yr) maltreatment prevalence NCANDS Binary single state analyses: criminal and civil child abuse (AL); reporting (MD); civil child abuse (UT) Original legal research Control for other prenatal drug policies by design Year and state indicators; % female poverty; % Black; substance use treatment facilities; overdose mortality
Boone & McMichael 2021
2005-2017 Longitudinal data with comparison group Any prenatal care prevalence; mean gestational length; mean APGAR; stillbirth prevalence; infant deaths (<1yr) prevalence; (county-month-level) NVSS Binary single policy (in one state): criminal (TN, fetal assault) Original legal research County and month fixed effects
Choi 2021
2010-2018 (FY) Longitudinal data with comparison groupA MOUD receipt TEDS-D Binary composite: criminal or civil child abuse (pre-existing) interacted with Medicaid expansion status Guttmacher State and year fixed effects; age; educational attainment; unemployment; race/ethnicity
Faherty 2019
2003-2014 Longitudinal data with comparison group NDWS diagnosis HCUP SIDS (8 states: AR, AZ, CO, KY, MA, MD, NV, UT) Binary composite: criminal or civil child abuse; involuntary commitment; and Binary single policy: mandatory reporting Guttmacher/original legal research State and year fixed effects; sex; preterm birth; race/ethnicity; payer; county urbanicity; targeted treatment facilities; % unemployed
Faherty 2022
2006-2014 Longitudinal data with comparison group NDWS diagnosis Medicaid MAX (39 states) Categorical composite: (criminal or civil child abuse, involuntary commitment) by timing: 1-yr post; 2-yrs; vs. no policy (3-level); and Binary single policy: mandatory reporting Guttmacher/original legal research Medicaid expansion; pregnancy discrimination prohibitions Preterm birth; infant sex; race/ethnicity; county urbanicity; % high school graduates; % unemployment; targeted treatment facilities
Gressler 2019
2007-2015 Longitudinal data no comparison group OUD diagnosis; MOUD receipt IQVIA PharMetrics Plus commercial claims Binary composite: civil or criminal penalty (components not specified) Not specified
Kozhimannil 2019
2002-2014 Longitudinal data with comparison group Treatment admissions among pregnant women out of admissions of reproductive age women (proportion) TEDS-A Categorical (8-levels) comparing: supportive (targeted treatment, priority access, pregnancy discrimination prohibitions); punitive (criminal or civil child abuse); mandatory testing/reporting Guttmacher Race and ethnicity, ageB State and year fixed effects; state-specific time trends
Maclean 2022
2004-2018 Longitudinal data with comparison group Maltreatment prevalence for: total; unsubstantiated; substantiated; substantiated (in which the mother was alleged perpetrator); (state-quarter-year-level) NCANDS Binary composite: criminal or civil child abuse; parental rights termination; and in sensitivity analyses ‘weaker’ punitive policies including CPS registry; abuse substantiation Original legal research Race and ethnicity; gender Cannabis legalization, GSL, Medicaid expansion; Medicaid income thresholds; NAL, pain clinic policies, PDMPs; priority treatment policies State and quarter- year fixed effects; governor’s political party; psychiatric providers pc; medical social workers pc; CPS workforce pc
Meinhofer 2022
2008-2018 Longitudinal data with comparison group NDWS (prevalence); LBW (prevalence); VLBW (prevalence) LGA (prevalence); any prenatal care (prevalence) HCUP SIDS (FastStats) and NVSS Binary composite: criminal or civil child abuse; parental rights termination; CPS registration Guttmacher/original legal research Income quartile (area-level), Medicaid status, rurality Medicaid income thresholds; priority treatment policies; and (in sensitivity analyses) pain clinic policies; cannabis legalization; Medicaid expansion; testing/reporting policies; SUD treatment funding State and year fixed effects; % Black (births); % Hispanic (Births); % male; unemployment rate; maternal age; and (in sensitivity analyses) drug seizures; taxes (beer/cigarette); SUD treatment providers
Sanmartin 2019
2005-2016 Longitudinal data with comparison group Infant foster care entries among all foster care; infant foster care entries citing parental drug or alcohol use AFCARS Binary composite: criminal or civil child abuse Guttmacher Race and ethnicity State and year fixed effects; median income; gender composition; % Black; % Hispanic; unemployment rate
Sanmartin 2020
2005-2017 Longitudinal data with comparison group Years from foster care entry to reunification AFCARS Binary composite: criminal or civil child abuse Guttmacher Race and ethnicity State and cohort fixed effects; race/ethnicity; sex
Tabatabaeepour 2022
2006–2019 Longitudinal data with comparison group MOUD receipt, psychosocial SUD treatment receipt; opioid prescriptions; opioid overdoses (fatal and nonfatal) MarketScan Commercial Claims Binary composite: criminal or civil child abuse, parental rights termination; CPS registration; and in sensitivity analyses categorical (3-level): criminal; strong punitive (civil child abuse or parental rights termination), weak punitive (all others) Guttmacher/original legal research Medicaid income thresholds, Medicaid expansion, PDMPs, pain clinic policies State and year-quarter fixed-effects; unemployment rate

Abbreviations: AFCARS, Adoption and Foster Care Analysis and Reporting System; CPS, Child protective services; FY, Fiscal Year; GSL, Good Samaritan saw; HCUP SIDS, Health Care Cost and Utilization Project State Inpatient Databases (linked birth data); MOUD, medications for opioid use disorder; MOUD: medications of opioid use disorder; NAL, naloxone access law; NCANDS, National Child Abuse and Neglect Data System; NCSL, National Conference of State Legislators; NDWS, neonatal drug withdrawal syndrome (also referred to as neonatal opioid withdrawal syndrome or neonatal abstinence syndrome); NVSS, National Vital Statistics System (linked birth data), OUD, opioid use disorder; PC, per capita. PDMP, prescription drug monitoring program; PRAMS, Pregnancy Risk Assessment and Monitoring Survey (linked birth data); Teds-A, Treatment Episode Dataset Admissions; TEDS-D, Treatment Episode Dataset Discharges. A Choi et al., specified punitive policy adoption as an effect measure modifier of the relationship between Medicaid expansion and MOUD receipt. B Kozhimannil et al., present results stratified by race and ethnicity but only among non-Hispanic white pregnant people.

Threats to validity

Threats to validity were concentrated in three areas, overall study design, control for time-varying confounding, and consideration of effect measure modification. First, in terms of study design, most included studies utilized a longitudinal approach with a comparison group (k=14), typically difference-in-differences implemented using two-way fixed effects or event study models. One early study employing treatment admissions data from 2012 was cross-sectional,63 and another was primarily descriptive, presenting only unadjusted analyses.64 Of the remaining longitudinal comparison group studies, all addressed common concerns in policy evaluation such as accounting for time trends (e.g., year or month fixed effects), including unit-specific effects (e.g., state fixed effects, generalized estimating equations, or by study design), and addressing serial correlation (e.g. clustered standard errors) where applicable. However, only some studies presented formal assumption testing analyses, such as parallel trends testing for difference-in-differences designs.65 While most included studies utilized national administrative data, five40,53,55,59,60 used a convenience sample of states or conducted single-state analyses.

Despite generally strong observational study designs, six40,53,66-69 of the included longitudinal studies did not control for co-occurring policies, and two53,67 did not control for any other theoretically relevant time-varying confounders. The co-occurring policies most frequently included in adjusted models were related to Medicaid (k=5),41,55,56,60,62 or were aimed at supporting pregnant people with drug use disorders—for example, policies mandating drug treatment access (k=5),57,58,60,62,67 or prohibiting treatment discrimination (n=2)55,67 during pregnancy. Eight studies also addressed policies that require health care providers to drug test, or to report evidence of prenatal drug use to child welfare or social services agencies for investigation (i.e., mandatory testing and reporting).40,41,55,57-60,67 Five of these treated mandatory reporting policies as an additional exposure category distinct from other punitive policies,40,55,59,60,67 while three treated them as covariates.41,57,58 Despite interdependencies between punitive mandatory reporting and civil child abuse policies, only one study considered joint effects.60 Five studies controlled for other treatment-related factors such as numbers of substance use disorder treatment providers, facilities, or funding levels within a state.40,41,55,59,60 Analytically accounting for the potentially countervailing effects of supportive policies and substance use disorder treatment capacity is an important consideration given that many states maintain both punitive and supportive policies.3,70 Several supportive-oriented policies are associated with increases in pregnant people’s use of treatment services and decreases in NDWS,41,67 though not all prior research is consistent.71

Lastly, only four studies considered the differential impacts that punitive policies may have on low-income pregnant people and pregnant people of color.41,62,67-69 Analyses of differential effects by race and ethnicity were included in three62,68,69 of the five studies examining maltreatment or foster care outcomes, but only in one of five studies67 on drug treatment. One additional study41 examined potential differential effects of punitive policies by income and Medicaid status on multiple pregnancy and birth-related outcomes.

Drug use disorder diagnosis and treatment and overdose

Drug use disorder diagnosis and treatment, including MOUD, were some of the most commonly assessed outcomes (Table 2).56,57,63,64,66,67 We did not identify any studies examining associations between punitive policies and measures of drug use directly, however studies in the treatment-related category hypothesized that inverse associations with punitive policies were indicative of reductions in treatment rather than reductions in drug use directly.

Two studies using national drug treatment admissions program data through 201457,67 reported that adoption of a criminal or civil child abuse policy was associated with an approximately 1-percentage-point decrease in the proportion of women who were pregnant upon entering drug treatment, suggesting treatment-inhibiting effects. Gressler et al.,64 additionally found a lower prevalence of opioid use disorder (OUD) diagnoses among pregnant people in punitive compared to non-punitive states in unadjusted analyses (Table 3).

Table 3.

Study findings by categories of outcomes evaluated

Author and year Main findings Overall punitive
policy impact
Maternal drug use disorder diagnosis and treatment, and overdose
Angelotta 2016 Compared to policy absence, presence of a punitive (criminal or civil child abuse) policy was associated with 43% higher odds of lack of planned MOUD (OR: 1.430 [95% CI: 1.260, 1.620) among pregnant women admitted to treatment programs for opioid use. Harmful
Atkins & Durrance 2020 Compared to states without punitive policies, punitive (civil child abuse) policy adoption was associated with a significant decrease in the proportion of treatment admissions among pregnant women (out of the total number of treatment admissions) (RD: −0.013 [95% CI: −0.030-0.000]). Harmful
Compared to states without punitive policies, adoption of a punitive (civil child abuse) policy was associated with a non-significant decrease in the prevalence of maternal narcotic exposure 1,000 hospital births (RD: −0.081 [95% CI: −0.216, 0.379]). No evidence to support benefit
Choi 2021 Compared to Medicaid expansion in states without punitive policies, Medicaid expansion in states with a punitive (civil or criminal child abuse) policy was associated with a non-significant decrease in MOUD among pregnant women with OUD (RD for the interaction term: −0.031 [95% CI: −0.101, 0.045]). No evidence to support benefit
Gressler 2019 Compared with states without punitive policies, prevalence of OUD diagnosis (difference: 0.110 [95% CI: 0.175, 0.447]) and MOUD receipt (difference: 0.050 [95% CI: −0.1051, 0.2051]) were lower in states with a punitive policy (components not specified). Descriptive
Kozhimannil 2019 Compared to states without any policies (punitive, supportive), adoption of a punitive (civil or criminal child abuse) policy was associated with a significant decrease in the proportion of treatment admissions among pregnant women (out of the total number of treatment admissions) (RD: −0.010 [95% CI: −0.018, −0.002]) Harmful
Tabatabaeepour 2022 Compared to pregnant women with OUD in states without punitive policies, and with non-pregnant women with OUD in states with a punitive policy, state adoption of a punitive (criminal or civil child abuse, parental rights termination, or CPS registration) policy was associated with a significant decrease in receipt of methadone (RD: −0.002 [95% CI: −0.004, 0.000]), and a significant decrease in receipt of psychosocial services (RD: −0.012 [95% CI: −0.021, −0.004]). Harmful
Compared to pregnant women with OUD in states without punitive policies, and non-pregnant women with OUD in states with a punitive policy, state adoption of a punitive (criminal or civil child abuse, parental rights termination, or CPS registration) policy was associated with a non-significant decrease in receipt of buprenorphine (RD: −0.005 [95% CI: −0.018, 0.008]), a non-significant decrease in receipt of naltrexone (RD: −0.001 [95% CI: −0.002, 0.001]), a non-significant decrease in opioid prescriptions (RD: −0.005 [95% CI: −0.022, 0.012]), and a non-significant increase in fatal or non-fatal opioid overdose (RD: 0.000 [95% CI: −0.004, 0.001]). No evidence to support benefit
Pregnancy-related outcomes and prenatal care utilization
Austin 2022 Compared to pregnant women in non-punitive states, state adoption of a child abuse policy only (RD: 0.440 [95% CI: 0.100, 0.780]), a mandated reporting policy only (RD: 0.320 [95% CI: 0.04, 0.59]), or both policies (RD: 0.400 [95% CI: 0.090, 0.720]) was significantly associated with later prenatal care initiation among pregnant women. Compared to pregnant women in non-punitive states, state adoption of a child abuse policy only (RD: −0.170 [95% CI: −0.240, −0.100]), was significantly associated with lower likelihood of adequate prenatal care receipt among pregnant women. Harmful
Compared to pregnant women in non-punitive states, state adoption of a mandated reporting policy only (RD: −0.060 [95% CI: 0.140, 0.010]) or a mandated child reporting policy and a child abuse policy RD: −0.040 [95% CI: −0.120 to 0.030] was non-significantly associated with a lower likelihood of adequate prenatal care receipt. No evidence to support benefit
Boone & McMichael 2021 Compared to states without fetal endangerment, adoption of fetal endangerment ([criminal, TN]) was associated with a significant decrease in the prevalence of prenatal care (RD: −0.062 [90% CI: −0.075, −0.049]), a significant decrease in mean Apgar score (RD: −0.125 [90% CI: −0.222, −0.028]), a significant increase in prevalence of stillbirth per 1,000 (RD: 0.225 [90% CI: 0.055 0.135, 0.315]), and a significant increase in prevalence of infant deaths per 1,000 (RD: 0.711 [90% CI: 0.474, 0.948]).B Harmful
Compared to states without fetal endangerment, adoption of fetal endangerment ([criminal, TN]) was associated with a non-significant decrease in mean gestational age (RD: −0.104 [90% 0.065 CI: −0.211, 0.003]). B No evidence to support benefit
Meinhofer 2022 Compared to states without punitive policies, adoption of punitive (criminal or civil child abuse, parental rights termination, or CPS registration) policy was associated with a non-significant decrease in the prevalence of LGA (RD: −0.011 [95% CI: −0.029, 0.007]), a non-significant increase in the prevalence of LBW (RD: 0.002 [95% CI: −0.012, 0.016]), and a non-significant increase in the prevalence of VLBW (RD: 0.012 [95% CI: −0.012, 0.036]). No evidence to support benefit
Compared to states without punitive policies, adoption of punitive (criminal or civil child abuse, parental rights termination, or CPS registration) policy was associated with a significant decrease in the prevalence of any prenatal care receipt (RD: −0.004 [95% CI: −0.008, 0.000]). Harmful
Neonatal drug withdrawal syndrome [NDWS]
Atkins & Durrance 2020 Compared to states without punitive policies, adoption of punitive (criminal or civil child abuse) policy was associated with a non-significant decrease in the prevalence of NDWS per 1,000 hospital births (RD: 0.100 [95% CI: −0.109, 0.309]). No evidence to support benefit
Faherty 2019 Compared to infants in states without punitive policies, adoption of a punitive (criminal or civil child abuse, civil commitment) policy was associated with a significant relative increase in the odds of NDWS among infants after 1 year after enactment (OR: 1.330 [95% CI: 1.170, 1.510]). Harmful
Faherty 2022 Compared to infants in states without punitive policies, adoption of a punitive (criminal or civil child abuse, involuntary commitment) policy was associated with a non-significant relative increase in the odds of NDWS among infants after 1 year after enactment (OR: 1.130 [95% CI: 0.880, 1.480]), and a non-significant relative increase in odds of NDWS among infants after 2 or more years of enactment (OR: 1.050 [95% CI: 0.810, 1.370]). No evidence to support benefit
Meinhofer 2022 Compared to states without punitive policies, adoption of punitive (criminal or civil child abuse, parental rights termination, or CPS registration) policy was associated with a significant increase in the prevalence of NDWS per 1,000 hospital births (RD: 0.176 [95% CI: 0.021, 0.331]). Further, NDWS increases were more pronounced among births financed by Medicaid. Harmful
Maltreatment reporting and foster care entry
Atkins & Durrance 2021 Compared to states without punitive policies, adoption of punitive (criminal or civil child abuse) policy was associated with a non-significant increase in the prevalence of foster care entry per 1,000 infant population (RD: 0.095 [95% CI: −0.006, 0.195]). No evidence to support benefit
Compared to states without punitive policies, adoption of punitive (criminal or civil child abuse) policy was associated with a significant increase in the prevalence of foster care entry associated with parental drug use and/or neglect per 1,000 infant population (RD: 0.141 [95% CI: 0.007, 0.276]). Harmful
Bandara 2022 Compared to control states (AK, CA, KY, MA, ME, MI, MT, PA), adoption of a punitive (civil child abuse in UT) policy was associated with a significant reduction in infant maltreatment reports, 4 years (RD: −0.272, 95% CI: −0.492, −0.53) and 5 years (RD: −0.310 95% CI: −0.612, −0.800) after the policy became effective. BeneficialB
Compared to control states (AK, CA, KY, MA, ME, MI, MT, PA), adoption of a punitive (civil and criminal child abuse in AL) policy was not associated with significant changes in infant maltreatment reports. No evidence to support benefit
MacLean 2022 Compared to states without punitive policies, adoption of a punitive (criminal, civil child abuse, parental rights termination) policy was associated with a significant increase in total (RD: 0.3541 [95% CI: 11.05]), substantiated (RD: 0.194 [95% CI: 0.719]) and substantiated in which the mother was the alleged perpetrator (RD: 0.177 [95% CI: 0.736)) infant maltreatment reports. Harmful
Sanmartin 2019 Compared to states without punitive policies, adoption of a punitive (criminal or civil child abuse) policy was associated with a significant increase in the proportion of foster care entry associated with parental substance use (out of all foster care entries) (RD: 0.071 [95% CI: 0.022, 0.119]). Harmful
Sanmartin 2020 Compared to infants in states without punitive policies, state adoption of a punitive (criminal or civil child abuse) policy was associated with a significant decrease in the relative chances of parental reunification among infants in foster care (HR: 0.950 [95% CI: 0.940, 0.960]). Harmful

CI: confidence interval; HR: hazards ratio; LGA: low gestational age (<37 weeks); LBW: low birthweight (<2,500g), NS: non-significant at the 0.05 threshold; OR: odds ratio; OUD: opioid use disorder; RD: risk difference; VLBW: very low birthweight (<1,500g). Punitive exposure status and statistical significance are identified per study descriptions. We calculated CIs for consistency across studies based on available standard error or p-value estimates when confidence intervals were not presented directly in study findings. For all studies except otherwise indicated, statistical significance was assessed at the 0.05 level. All estimates were rounded to 3 decimal points from the original presented values for consistency. A For Boone and McMichael, the authors provided additional data on standard errors which were used to calculate 90% CIs which was the definition of statistical significance used in the study (Benjamin McMichael, JD PhD, email, 9/1/2022). B It should be noted that although associations were classified as potentially beneficial, statistically significant findings were only reported for some of the individual years post-enactment and should therefore be interpreted with caution.

Among pregnant people diagnosed with OUD, two additional studies reported reduced use of MOUD generally,63 methadone56 and psychosocial drug treatment56 (but not buprenorphine use), in punitive compared to non-punitive states. Choi et al.66 further examined associations between Medicaid expansion and MOUD in both punitive (criminal or civil child abuse) and non-punitive states. They found that while expansion was associated with increases in MOUD broadly, increases were relatively smaller in punitive contexts (8.7 versus 5.6 percentage points), but not statistically significant in formal interaction testing. Lastly, Tabatabaeepour et al.,56 analyzing commercial insurance claims, found that punitive policies overall were not associated with changes in fatal or non-fatal overdose among pregnant people with OUD. However, in some sensitivity analyses there was an imprecise relationship between criminalization and increasing non-fatal overdose prevalence, highlighting that further research is needed to better characterize the impacts of criminal policies specifically.

Pregnancy and birth-related outcomes and prenatal care utilization

Three studies41,53,60 examined associations of punitive policies with pregnancy and birth-related outcomes (Table 3). Each found that punitive policy adoption adversely affected measures of prenatal care, but results were inconclusive for other outcomes. First, using 2008–2019 U.S. birth data, Meinhofer et al.,41 found that adoption of any punitive policy (criminalization, civil child abuse, parental rights termination and maltreatment registry requirements—policies requiring individuals investigated/convicted of child abuse to be place on state registries) was associated with decreased utilization of any prenatal care. Austin et al.60 likewise found that child abuse policies alone, and child abuse policies adopted in conjunction with mandatory reporting, were both associated with delays in prenatal care initiation. Lastly, Boone and McMichael,53 focusing on the Tennessee Fetal Assault statute, identified decreases in the county-level prevalence of any prenatal care following enactment, relative to counties in control states without criminalization.

Despite the generally consistent finding that punitive policies adversely impact uptake of prenatal care, results were more mixed for other birth outcomes. Boone and McMichael found that the Tennessee Fetal Assault statute adversely affected mean Apgar score, stillbirth, and infant mortality but not mean gestational age.53 Similarly, Meinhofer et al.41 reported that punitive policies were associated with imprecise increases in low-birthweight and very low-birthweight and decreases in gestational age.

Neonatal drug withdrawal syndrome (NDWS)

The four studies that examined relationship of punitive policies with prevalence or individual odds of NDWS also suggested null or harmful results (Table 3).40,41,55,57 It is important to note that in the context of NDWS, increases in prevalence following policy adoption are challenging to interpret given that NWDS can also be caused by MOUDs like methadone—the historical gold standard of care for treating OUD among pregnant people.8

In hospital discharge data from 37 states 2000-2016, Atkins and Durrance57 identified a 10%–14% increase in NDWS prevalence in states adopting a civil child abuse policy, relative to comparators. Using the same data source, but restricting to the 2008-2018 period, Meinhofer et al.,41 found that punitive policies were associated with greater NDWS prevalence at approximately the same magnitude. Further, the authors reported that punitive policies specifically increased NDWS among births covered by Medicaid and births to lower-income people.

Two studies assessing NDWS at the individual-level also reported inconsistent findings. Faherty et al.,40 tested whether the enactment of any policy related to criminal or civil child abuse or civil commitment, was associated with changes in odds of NDWS. Across the eight included states, these policies as a group predicted a 17-51% relative increase in the odds of NDWS 1-year after enactment. However, given that none of these eight states appear to have authorized criminalization or civil commitment during the study timeframe, these findings may be limited to enactment of civil child abuse statutes. In a second study by Faherty et al.,55 evaluating NDWS within a sample of births to people covered by Medicaid, the authors found that any punitive policy (criminal child abuse, civil child abuse, involuntary commitment) adoption was associated with small imprecise relative increase in NDWS odds 1-year (OR: 1.130 [95% CI: 0.880, 1.480]) and 2-years (OR: 1.050 [95% CI: 0.810, 1.370]) post-policy.

Child maltreatment and foster care

Five studies that used national maltreatment or foster care records reported null or adverse associations with punitive policies (Table 3).58,59,62,68,69 First, Maclean et al.62 identified increases in total (19%) and substantiated (33%) reported infant maltreatment prevalence in states adopting a criminal or civil child abuse, or parental rights termination policy, relative to control states. Associations were especially pronounced among Black infants, suggesting differentially harmful effects by race and ethnicity. In contrast to these overall results, however, an additional study reported inconclusive findings for states implementing civil child abuse policies alone, or in combination with criminalization.59 Bandara et al.59 identified a potentially beneficial association—depending on interpretation—between civil child abuse policy adoption and reported infant maltreatment prevalence in a single state (UT) compared to a selection of comparison states (AK, CA, KY, MA, ME, MI, MT, PA). Although reductions in maltreatment prevalence were not observed in Utah in the first three years following enactment, decreases in maltreatment were noted four years post-enactment, relative to controls. In contrast, the study also reported that the coadoption of civil and criminal child abuse in Alabama was not associated with meaningful changes in maltreatment. As noted by the authors, however, reductions in observed maltreatment could reflect a chilling effect on reporting, rather than reductions in maltreatment incidents directly, making it challenging to interpret findings without broader context.

For foster care, Sanmartin et al,68 found increases in the prevalence of substance use-related foster care entries in states that newly adopted a criminal or civil child abuse policy between 2005 and 2016. They also reported that while the increase was observed for both non-Hispanic white and Black children, impacts were concentrated among non-Hispanic white infants. These findings were similar to those of Atkins and Durrance,58 who likewise identified an approximately 10% increase in foster care entries among infants removed for parental drug use-related reasons in punitive states. In a second study, Sanmartin et al.69 also found that among infants in foster care for reasons related to parental substance use, lower parental reunification was observed among infants in non-punitive states. Further, while infants experienced reduced parental reunification in punitive contexts overall (Hazzard Ratio [HR]: 0.87; 95% confidence interval, 0.86-0.88), non-Hispanic white infants were more likely to be reunited, suggesting more profound adverse impacts for Black families.

Discussion

In this legal survey and systematic literature review, we first characterized the status of U.S. punitive prenatal drug policies, then summarized the empirical literature evaluating their public health consequences. Three primary conclusions emerged from this process. First, while close to half of U.S. states have adopted some type of punitive legislation, the triggering circumstances and severity of penalties vary dramatically across states and policy categories. Some state statutes are ambiguous; depending on enforcement, pregnant people may face unpredictably large penalties associated with drug use that could affect how they respond to them. Subtleties and uncertainties between and within punitive policy categories present analytic challenges for related evaluation research.49,50 Nevertheless, these sources of heterogeneity may also present important opportunities for researchers to explore which legislative components have the most impact, either beneficially or detrimentally.

Second, the literature review indicated that punitive policy approaches do not appear to predict improvements in health outcomes. In fact, most studies reported harms associated with at least one outcome under consideration. Of the 16 studies reviewed (excluding one descriptive study)64, six reported only harmful associations,40,56,62,63,68,69 six reported a combination of null and harmful associations,41,53,56-58,60 and two reported only null associations.55 One additional study reported both a null and a potentially beneficial association;59 adoption of civil child abuse in Utah was associated with decreased infant maltreatment reporting after four years of enactment. However, this finding was limited to a single state exposure, somewhat conflicted with other study results, and directionality was subject to interpretation, as noted by the authors.

Despite multiple studies suggesting harm, broader generalizability is challenging, due to differences in data, design, and other methodological choices. In terms of data, the limited availability of rigorous longitudinal information on linked birthing parent-infant dyads complicates inferences. For example, as noted previously, NWDS can result from both non-prescribed and prescribed opioids, meaning that any policy-associated changes would preferably be evaluated in the context of linked MOUD status. Except for those evaluating both pregnancy and birth-related outcomes, studies tended to focus on either the pregnant person or the infant, but not both. Linked dyad data could also help to address potentially relevant sources of residual confounding like nutritional status and tobacco use, which are known to vary by state and impact multiple pregnancy-related outcomes.

Beyond data, the complexity of appropriately operationalizing policy exposures presented another key challenge. As implied above, specific individual policies may have had differential impacts on pregnant people themselves, healthcare providers or institutions, and law enforcement practices, in ways that affect the outcomes under investigation. Most included studies assessed impacts of any punitive policy (presence or absence), rather than individual policies specifically. Further, given disagreements between studies regarding legislative timing, additional exposure misclassification remains a strong possibility. Several studies that empirically isolated policies with the potential for liberty deprivations (i.e., explicit criminalization, involuntary commitment) consistently reported harmful associations, rather than reporting mixed or null findings—often with higher magnitudes. On balance, this evidence suggests that punitive legal approaches are more likely harmful than helpful. Together, however, these findings also highlight the need for a more systematic approach to policy classification, and greater attention to the underlying mechanisms that might be driving associations.

A final important conclusion was that while most studies suggested harms, few considered racialized or income-related differences in policy effects. Given that over 50% of historically prosecuted cases have targeted Black pregnant people,26 and in 71% of cases the person prosecuted qualified for income-based legal assistance, punitive policy expansion has the potential to exacerbate many existing health disparities.5,26,72 At the same time, only five of 16 studies considered effect measure modification by social indicators. Of the studies examining racialized consequences, three evaluated associations with maltreatment or foster care outcomes and one evaluated associations with drug treatment. Studies in other outcome categories generally ignored policy heterogeneity by race and ethnicity but one key study looked at income differences (for NDWS and pregnancy and birth outcomes).41 Given that the overall evidence suggests that punitive policies likely create health harms, it is especially critical for future research to assess how specific punitive policies may differentially impact subgroups of pregnant people, and the degree to which these differences contribute to health disparities.

Limitations

This review had limitations. First, we imposed multiple restrictions to manage the complexity of the review but acknowledge that these decisions imply tradeoffs. For example, we excluded legal mechanisms that did not directly impose penalties on pregnant people themselves, including mandatory reporting policies which typically target providers.34 The evaluation of mandatory reporting policies, which are fundamentally punitive in nature,8 is an active area of ongoing research, but one that was outside the scope of this initial review. We similarly excluded polices aimed at supporting pregnant people with drug use disorder, another important area for further investigation. A related issue is that this review focused solely on policies on the books (as enacted), without tracking enforcement or “on the ground” impact. Relatedly, we did not conduct a systematic search for case citations, only for legislation. Our search was similarly not designed to reflect settings where prenatal drug use could be considered legally relevant in the absence of a specific statute, including in states that have adopted other fetal personhood measures.73

Several scoping-related limitations also apply to the systematic review. For example, we may have missed important studies published after our search window was closed, and that were conducted in other settings. Prenatal substance use is not limited to the U.S., and evidence indicates that multiple other countries including Australia, Canada, Norway, South Africa and the U.K. have adopted or are considering policies that can result in punitive consequences for pregnant people who use drugs.74-78 Given that these policies likely operate similarly across contexts, we would expect punitive policies to also exert adverse health consequences in these settings. Additional research is needed to explore this possibility. Triangulating findings in an international perspective could also strengthen the broader evidence base by leveraging population registries with more comprehensive dyadic data to address observed shortcomings of U.S.-based studies.79 Regardless of setting, as legislative and epidemiologic contexts evolve, additional research is warranted. Emerging data suggests that the prevalence of prenatal substance use and related outcomes like overdose increased in many places during the COVID-19 pandemic.80-83 How these trends may have been affected by policy environments is unclear.

Lastly, another limitation is that we did not conduct a meta-analysis given differences in variable definitions and few studies in some outcome categories. However, as previously noted, while this methodological diversity complicates generalizations about the potentially harmful effects of specific punitive policies, the consistency of null or adverse associations across relatively dissimilar studies increases our confidence that these policies do not yield benefits.

Conclusions

Our findings suggest that nearly half of states have adopted policies imposing penalties on prenatal drug use. This means that a significant proportion of pregnant people who use drugs in the U.S. face potential legal implications. Moreover, the existing evidence base does not support this policy approach. While we found relatively consistent evidence that punitive approaches do not improve health, there was not enough evidence to definitively conclude that policies increase harms—at least for most exposure-outcome combinations. An important factor likely contributing to this uncertainly is that most studies assessed the effects of combinations of policy exposures, without disaggregating specific policies in the analysis. Additional research is therefore required to better characterize the pathways through which punitive legal approaches may result in unintended harmful consequences, particularly for explicit criminalization, parental rights termination, and involuntary commitment, which remain understudied. Further, given the strong possibility that punitive policies engender adverse health consequences, future work must investigate potential differential effects among families known to be unequally and unfairly targeted by criminal-legal system enforcement.

Supplementary Material

1

Highlights.

  • Nealy half of U.S. states have adopted punitive prenatal drug use policies.

  • Existing literature consistently identifies few health benefits associated with punitive policies.

  • Evidence for potential harmful effects requires additional research.

  • Identifying effective policy strategies to support pregnant people with drug use disorder outside of the criminal-legal system is an important priority.

Acknowledgements:

This research was supported by funding from the National Institute on Drug Abuse (grants R01053745 and R01031099 to SSM). EB is funded by the National Institute on Drug Abuse (T32DA031099). The sponsors had no role in the study design, collection, analyses, or interpretation of data, or in the writing of the report or decisions to submit the article for publication. The authors would like to thank Megan Marziali for providing comments and expertise on prenatal substance use policies in an international setting.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Declaration of interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Ethics approval

The authors declare that the work reported herein did not require ethics approval because it did not involve animal or human participation.

References:

  • 1.Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health 2022 NSDUH Detailed Tables. Table 8.27B – Substance Use in Past Month: Among Females Aged 15 to 44; by Pregnancy Status, Percentages, 2021 and 2022. Published 2023. https://www.samhsa.gov/data/report/2022-nsduh-detailed-tables
  • 2.Drabble L, Thomas S, O’Connor L, Roberts SCM. State Responses to Alcohol Use and Pregnancy: Findings From the Alcohol Policy Information System. J Soc Work Practice Addictions. 2014;14(2): 191–206. doi: 10.1080/1533256X.2014.900409 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Thomas S, Treffers R, Berglas NF, Drabble L, Roberts SCM. Drug Use During Pregnancy Policies in the United States From 1970 to 2016. Contemp Drug Prob. 2018;45(4):441–459. doi: 10.1177/0091450918790790 [DOI] [Google Scholar]
  • 4.Hearing on H.B. 1295. 105th Tennessee General Assembly, 62nd Legislative Day.; 2014. Accessed July 14, 2022. https://tnga.granicus.com/MediaPlayer.php?view_id=269&clip_id=9325
  • 5.Bach WA. Prosecuting Poverty, Criminalizing Care. Cambridge University Press; 2022. [Google Scholar]
  • 6.Markowitz JD, Frierson RL. The prosecution and civil commitment of pregnant women who abuse drugs: A review and commentary. Am J Forens Psychiatry Psychol. 2006;27(2):33–44. [Google Scholar]
  • 7.Terplan M, Kennedy-Hendricks A, Chisolm MS. Article Commentary: Prenatal Substance Use: Exploring Assumptions of Maternal Unfitness. Subst Abuse. 2015;9s2:SART.S23328. doi: 10.4137/SART.S23328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Goodman D, Whalen B, Hodder LC. It’s Time to Support, Rather Than Punish, Pregnant Women With Substance Use Disorder. JAMA Netw Open. 2019;2(11):e1914135. doi: 10.1001/jamanetworkopen.2019.14135 [DOI] [PubMed] [Google Scholar]
  • 9.Volkow ND. Pregnant People With Substance Use Disorders Need Treatment, Not Criminalization. National Institute on Drug Abuse. Published February 15, 2023. Accessed April 17, 2023. http://nida.nih.gov/about-nida/noras-blog/2023/02/pregnant-people-substance-use-disorders-need-treatment-not-criminalization [Google Scholar]
  • 10.American College of Obstetricians and Gynecologists. Committee opinion no. 633: Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Obstet Gynecol. 2015;125(6):1529–1537. doi: 10.1097/01.AOG.0000466371.86393.9b [DOI] [PubMed] [Google Scholar]
  • 11.American College of Obstetricians and Gynecologists. Opioid Use and Opioid Use Disorder in Pregnancy, Committee Opinion 711. Published 2021. Accessed April 17, 2023. https://www.acog.org/en/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy
  • 12.Roberts D. Misconceiving mothers: Legislators, prosecutors, and the politics of prenatal drug exposure. J Criminal Law Criminology. 2000;90(4):1353–1370. doi: 10.2307/1144205 [DOI] [Google Scholar]
  • 13.Roberts SCM, Thompson TA, Taylor KJ. Dismantling the legacy of failed policy approaches to pregnant people’s use of alcohol and drugs. International Review of Psychiatry. 2021;33(6):502–513. doi: 10.1080/09540261.2021.1905616 [DOI] [PubMed] [Google Scholar]
  • 14.Lester BM, Andreozzi L, Appiah L. Substance use during pregnancy: time for policy to catch up with research. Harm Reduction J. 2004;1:5–44. doi: 10.1186/1477-7517-1-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Flavin J, Paltrow LM. Punishing Pregnant Drug-Using Women: Defying Law, Medicine, and Common Sense. J Addict Dis. 2010;29(2):231–244. doi: 10.1080/10550881003684830 [DOI] [PubMed] [Google Scholar]
  • 16.Bridges KM. Race, Pregnancy, and the Opioid Epidemic: White Privilege and the Criminalization of Opioid Use During Pregnancy. Harv L Rev. 2020; 133(3): 770. [Google Scholar]
  • 17.Faherty LJ, Stein BD, Terplan M. Consensus Guidelines and State Policies: The Gap Between Principle and Practice at the Intersection of Substance Use and Pregnancy. AJOG. 2020;2(3): 100137. doi: 10.1016/j.ajogmf.2020.100137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Darlington CK, Compton PA, Hutson SP. Revisiting the Fetal Assault Law in Tennessee: Implications and the Way Forward. Policy Polit Nurs Pract. 2021;22(2):93–104. doi: 10.1177/1527154421989994 [DOI] [PubMed] [Google Scholar]
  • 19.Shearer JN, Erwin PC, Davis SK, Anderson JG, Lindley LC. Implications of Tennessee’s Opioid Legislation for Neonatal Abstinence Syndrome. Policy Polit Nurs Pract. 2019;20(3): 153–162. doi: 10.1177/1527154419864540 [DOI] [PubMed] [Google Scholar]
  • 20.Carroll JJ, El-Sabawi T, Ostrach B. The harms of punishing substance use during pregnancy. Int J Drug Policy. 2021;98:103433. doi: 10.1016/j.drugpo.2021.103433 [DOI] [PubMed] [Google Scholar]
  • 21.Fischer G. Substance dependent women and pregnancy-Human rights based approach to research and policy. Drug Alcohol Rev. 2017;36:4–5. doi: 10.1097/ADM.0000000000000565 [DOI] [PubMed] [Google Scholar]
  • 22.Hui K, Angelotta C, Fisher CE. Criminalizing substance use in pregnancy: misplaced priorities. Addiction. 2017; 112(7): 1123–1125. doi: 10.1111/add.13776 [DOI] [PubMed] [Google Scholar]
  • 23.Jacobson PD, Zellman GL, Fair CC. Reciprocal Obligations: Managing Policy Responses to Prenatal Substance Exposure. Milbank Quarterly. 2003;81(3):475. doi: 10.1111/1468-0009.t01-1-00064 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Patrick SW, Schiff DM, Committee on Substance Use Prevention, et al. A Public Health Response to Opioid Use in Pregnancy. Pediatrics. 2017;139(3):e20164070.doi: 10.1542/peds.2016-4070 [DOI] [PubMed] [Google Scholar]
  • 25.Shepherd JP. Criminal deterrence as a public health strategy. Lancet. 2001;358(9294): 1717–1722. doi: 10.1016/S0140-6736(01)06716-2 [DOI] [PubMed] [Google Scholar]
  • 26.Paltrow LM, Flavin J. Arrests of and forced interventions on pregnant women in the United States, 1973-2005: implications for women’s legal status and public health. J Health Polit Policy L. 2013;38(2):299–343. doi: 10.1215/03616878-1966324 [DOI] [PubMed] [Google Scholar]
  • 27.Roberts SCM, Zahnd E, Sufrin C, Armstrong MA. Does adopting a prenatal substance use protocol reduce racial disparities in CPS reporting related to maternal drug use? A California case study. J Perinatal. 2015;35(2):146–150. doi: 10.1038/jp.2014.168 [DOI] [PubMed] [Google Scholar]
  • 28.Roberts SCM, Nuru-Jeter A. Universal Alcohol/Drug Screening in Prenatal Care: A Strategy for Reducing Racial Disparities? Questioning the Assumptions. Matern Child Health J. 2011;15(8):1127–1134. doi: 10.1007/s10995-010-0720-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Perez YM. Ferguson v. City of Charleston and Criminalizing Drug Use During Pregnancy. AMA J Ethics. 2013;15(9):771–774. doi: 10.1001/virtualmentor.2013.15.9.hlaw1-1309 [DOI] [PubMed] [Google Scholar]
  • 30.Jarlenski M, Shroff J, Terplan M, Roberts SCM, Brown-Podgorski B, Krans EE. Association of Race With Urine Toxicology Testing Among Pregnant Patients During Labor and Delivery. JAMA Health Forum. 2023;4(4):e230441. doi: 10.1001/jamahealthforum.2023.0441 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.M RSC, Zahnd E, Sufrin C, Armstrong MA. Does adopting a prenatal substance use protocol reduce racial disparities in CPS reporting related to maternal drug use? A California case study. J Perinatol. 2015;35(2):146–150. doi: 10.1038/jp.2014.168 [DOI] [PubMed] [Google Scholar]
  • 32.Roberts SCM, Thomas S, Treffers R, Drabble L. Forty Years of State Alcohol and Pregnancy Policies in the USA: Best Practices for Public Health or Efforts to Restrict Women’s Reproductive Rights? Alcohol Alcohol. 2017;52(6):715–721.doi: 10.1093/alcalc/agx047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Davis MD. Bad Moms and Powerful Prosecutors: Why a Public Health Approach to Maternal Drug Use Is Necessary to Lessen the Hardship Borne by Women in the South. Geo J on Poverty L Pol. 2017;25(2):305–322. [Google Scholar]
  • 34.Jarlenski M, Hogan C, Bogen DL, Chang JC, Bodnar LM, Van Nostrand E. Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use. Women Health. 2017;27(3):264–270. doi: 10.1016/j.whi.2016.12.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Miranda L, Dixon V, Reyes C. How States Handle Drug Use During Pregnancy. Published 2015. Accessed October 10, 2022. http://projects.propublica.org/graphics/maternity-drug-policies-by-state [Google Scholar]
  • 36.Administration for Child and Families, Children’s Bureau. Parental Substance Use as Child Abuse. Published 2022. Accessed July 16, 2022.https://www.childwelfare.gov/topics/systemwide/laws-policies/statutes/parentalsubstanceuse/
  • 37.Weigel G, Sobel L, Salganicoff A. Criminalizing Pregnancy Loss and Jeopardizing Care: The Unintended Consequences of Abortion Restrictions and Fetal Harm Legislation. Women Health. 2020;30(3): 143–146. doi: 10.1016/j.whi.2020.03.005 [DOI] [PubMed] [Google Scholar]
  • 38.Lloyd MH, Luczak S, Lew S. Planning for safe care or widening the net?: A review and analysis of 51 states’ CAPTA policies addressing substance-exposed infants. Child Youth Serv Rev. 2019;99:343–354. doi: 10.1016/j.childyouth.2019.01.042 [DOI] [Google Scholar]
  • 39.Thomas S, Treffers R, Berglas NF, Drabble L, Roberts SCM. Drug Use During Pregnancy Policies in the United States From 1970 to 2016. Contemp Drug Prob. 2018;45(4):441–459. doi: 10.1177/00914509187907 [DOI] [Google Scholar]
  • 40.Faherty LJ, Kranz AM, Russell-Fritch J, Patrick SW, Cantor J, Stein BD. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome. JAMA Netw Open. 2019;2(11):e1914078.doi: 10.1001/jamanetworkopen.2019.14078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Meinhofer A, Witman A, Maclean JC, Bao Y. Prenatal substance use policies and newborn health. J Health Econ. 2022;31(7): 1452–1467. doi: 10.1002/hec.4518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Salihu HM, Mogos MF, Salinas-Miranda AA, Salemi JL, Whiteman VE. National Trends in Maternal Use of Opioid Drugs among Pregnancy-Related Hospitalizations in the United States, 1998 to 2009. Am J Perinatol. 2015;32(3):289–298. doi: 10.1055/s-0034-1384642 [DOI] [PubMed] [Google Scholar]
  • 43.Admon LK, Bart G, Kozhimannil KB, Richardson CR, Dalton VK, Winkelman TNA. Amphetamine- and Opioid-Affected Births: Incidence, Outcomes, and Costs, United States, 2004–2015. Am J Public Health. 2019;109(1): 148–154. doi: 10.2105/AJPH.2018.304771 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schuler MS, Heins SE, Smart R, et al. The state of the science in opioid policy research. Drug Alcohol Depend. 2020;214:108137. doi: 10.1016/j.drugalcdep.2020.108137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Saeed S, Moodie EEM, Strumpf EC, Klein MB. Evaluating the impact of health policies: using a difference-in-differences approach. Int J Public Health. 2019;64(4): 637–642. doi: 10.1007/s00038-018-1195-2 [DOI] [PubMed] [Google Scholar]
  • 46.Schuler MS, Griffin BA, Cerdá M, McGinty EE, Stuart EA. Methodological Challenges and Proposed Solutions for Evaluating Opioid Policy Effectiveness. Health Serv Outcomes Res Methodol. 2021;21(1):21–41. doi: 10.1007/s10742-020-00228-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Matthay EC, Glymour MM. Causal Inference Challenges and New Directions for Epidemiologic Research on the Health Effects of Social Policies. Curr Epidemiol Rep. 2022;9(1):22–37. doi: 10.1007/s40471-022-00288-7 [DOI] [Google Scholar]
  • 48.Matthay EC, Hagan E, Gottlieb LM, et al. Alternative causal inference methods in population health research: Evaluating tradeoffs and triangulating evidence. SSM Popul Health. 2020;10:100526. doi: 10.1016/j.ssmph.2019.100526 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Matthay EC, Gottlieb LM, Rehkopf D, Tan ML, Vlahov D, Glymour MM. What to Do When Everything Happens at Once: Analytic Approaches to Estimate the Health Effects of Co-Occurring Social Policies. Epidemiol Rev. 43:33–47. doi: 10.1093/epirev/mxab005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Matthay EC, Hagan E, Joshi S, et al. The Revolution Will Be Hard to Evaluate: How Co-Occurring Policy Changes Affect Research on the Health Effects of Social Policies. Epidemiol Rev. 2021;43(1): 19–32. doi: 10.1093/epirev/mxab009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Roth J, Sant’Anna PHC, Bilinski A, Poe J. What’s Trending in Difference-in-Differences? A Synthesis of the Recent Econometrics Literature. Published online January 9, 2023.Accessed February 2, 2023. http://arxiv.org/abs/2201.01194 [Google Scholar]
  • 52.Basu S, Meghani A, Siddiqi A. Evaluating the Health Impact of Large-Scale Public Policy Changes: Classical and Novel Approaches. Annu Rev Public Health. 2017;38:351–370. doi: 10.1146/annurev-publhealth-031816-044208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Boone M, McMichael BJ. State-Created Fetal Harm. Georgetown Law J. 2021;109:475. [Google Scholar]
  • 54.Suppé R. Pregnancy on Trial: The Alabama Supreme Court’s Erroneous Application of Alabama’s Chemical Endangerment Law in Ex parte Ankrom. Health L Pol. 2014;7(2):28. [Google Scholar]
  • 55.Faherty LJ, Heins S, Kranz AM, Patrick SW, Stein BD. Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments. Addiction. 2022;117(1):162–171. doi: 10.1111/add.15602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Tabatabaeepour N, Morgan JR, Jalali A, Kapadia SN, Meinhofer A. Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder. J Subst Abuse Treat. 2022;140. doi: 10.1016/j.jsat.2022.108800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Atkins DN, Durrance CP. State Policies That Treat Prenatal Substance Use As Child Abuse Or Neglect Fail To Achieve Their Intended Goals. Health Aff. 2020;39(5):756–763.doi: 10.1377/hlthaff.2019.00785 [DOI] [PubMed] [Google Scholar]
  • 58.Atkins DN, Durrance CP. The impact of state-level prenatal substance use policies on infant foster care entry in the United States. Child Youth Serv Rev. 2021; 130:106194.doi: 10.1016/j.childyouth.2021.106194 [DOI] [Google Scholar]
  • 59.Bandara S, Schall TE, White SA, McCourt AD, Goodman D, McGinty EE. Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah. Int J Drug Policy. 2022;108:103806. doi: 10.1016/j.drugpo.2022.103806 [DOI] [PubMed] [Google Scholar]
  • 60.Austin AE, Naumann RB, Simmons E. Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy. JAMA Pediatr. 2022;176(11):1123–1130. doi: 10.1001/jamapediatrics.2022.3396 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Reddy J, Schiff D. A response to ‘Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments’. Addiction. 2022;117(3):833–834. doi: 10.1111/add.15650 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Maclean JC, Witman A, Durrance CP, Atkins DN, Meinhofer A. Prenatal Substance Use Policies and Infant Maltreatment Reports. Health Aff. 2022;41(5):703–712.doi: 10.1377/hlthaff.2021.01755 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Angelotta C, Weiss CJ, Angelotta JW, Friedman RA. A Moral or Medical Problem? The Relationship between Legal Penalties and Treatment Practices for Opioid Use Disorders in Pregnant Women. Women Health. 2016;26(6):595–601. doi: 10.1016/j.whi.2016.09.002 [DOI] [PubMed] [Google Scholar]
  • 64.Gressler LE, Shah S, Shaya FT. Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States. JAMA Netw Open. 2019;2(3):e190338.doi: 10.1001/jamanetworkopen.2019.0338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Wing C, Simon K, Bello-Gomez RA. Designing Difference in Difference Studies: Best Practices for Public Health Policy Research. Annu Rev Public Health. 2018;39(1):453–469. doi: 10.1146/annurev-publhealth-040617-013507 [DOI] [PubMed] [Google Scholar]
  • 66.Choi S, Stein MD, Raifman J, Rosenbloom D, Clark JA. Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy. Drug Alcohol Depend. 2021;229(Pt A):109162.doi: 10.1016/j.drugalcdep.2021.109162 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Kozhimannil KB, Dowd WN, Ali MM, Novak P, Chen J. Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database. Addict Behav. 2019;90:272–277. doi: 10.1016/j.addbeh.2018.11.019 [DOI] [PubMed] [Google Scholar]
  • 68.Sanmartin MX, Ali MM, Lynch S. Foster care admissions and state-level criminal justice-focused prenatal substance use policies. Child Youth Serv Rev. 2019;102:102–107. doi: 10.1016/j.childyouth.2019.03.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Sanmartin MX, Ali MM, Lynch S, Aktas A. Association Between State-Level Criminal Justice-Focused Prenatal Substance Use Policies in the US and Substance Use-Related Foster Care Admissions and Family Reunification. JAMA Pediatr. 2020;174(8):782–788. doi: 10.1001/jamapediatrics.2020.1027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.White SA, McCourt A, Bandara S, Goodman DJ, Patel E, McGinty EE. Implementation of State Laws Giving Pregnant People Priority Access to Drug Treatment Programs in the Context of Coexisting Punitive Laws. Women Health. Published online October 19, 2022:S1049-3867(22)00108-6. doi: 10.1016/j.whi.2022.09.001 [DOI] [PubMed] [Google Scholar]
  • 71.Davis CS, McNeer E, Patrick SW. Laws Forbidding Pregnancy Discrimination in Substance Use Disorder Treatment Are Not Associated With Treatment Access. J Addict Med.2022; 16(3):364. doi: 10.1097/ADM.0000000000000897 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Howard GE. The Criminalization of Pregnancy: Rights, Discretion, and the Law. Rutgers The State University of New Jersey-New Brunswick; 2017. [Google Scholar]
  • 73.Paltrow LM. Roe v Wade and the New Jane Crow: Reproductive Rights in the Age of Mass Incarceration. Am J Public Health. 2022; 112(9):1313–1317. doi: 10.2105/AJPH.2012.301104r [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Sistovaris M, Sansone G, Fallon B, Miller S. The Efficacy of Birth Alerts: Fact Sheet. Policy Bench, Fraser Mustard Institute of Human Development, University of Toronto. https://socialwork.utoronto.ca/wp-content/uploads/2022/08/Lit-Scan-Efficacy-of-Birth-Alerts-Jan12.pdf [Google Scholar]
  • 75.Söderström K, Skolbekken JA. Pregnancy and substance use – the Norwegian z 10–3 solution. 1 Ethical and clinical reflections related to incarceration of pregnant women to protect the foetus from harmful substances. Nordic Studies on Alcohol and Drugs. 2012;29(2): 155–171. doi: 10.2478/v10199-012-0011-1 [DOI] [Google Scholar]
  • 76.Kenny MC, Mathews B, Pathirana M. Responses to prenatal opioid and alcohol abuse: A review of US and Australian mandatory reporting laws. Child Abuse Review. 2023;32(1):1–10. doi: 10.1002/car.2775 [DOI] [Google Scholar]
  • 77.Ovens M. A criminological perspective on the prenatal abuse of substances during pregnancy and the link to child abuse in South Africa. Early Child Development and Care.2009; 179(4): 503–516. doi: 10.1080/03004430701269242 [DOI] [Google Scholar]
  • 78.Gilmour L, Honeybul L, Lewis S, et al. Scoping review: mapping clinical guidelines and policy documents that address the needs of women who are dependent on drugs during the perinatal period. BMC Pregnancy Child birth. 2024;24:84. doi: 10.1186/s12884-023-06172-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Laugesen K, Ludvigsson JF, Schmidt M, et al. Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries. CLEP. 2021;Volume 13:533–554. doi: 10.2147/CLEP.S314959 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Kar P, Tomfohr-Madsen L, Giesbrecht G, Bagshawe M, Lebel C. Alcohol and substance use in pregnancy during the COVID-19 pandemic. Drug and Alcohol Dependence. 2021;225:108760. doi: 10.1016/j.drugalcdep.2021.108760 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Young-Wolff KC, Ray GT, Alexeeff SE, et al. Rates of Prenatal Cannabis Use Among Pregnant Women Before and During the COVID-19 Pandemic. JAMA. 2021;326(17):1745–1747. doi: 10.1001/jama.2021.16328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.MacMillan KDL, Morrison TM, Melvin P, Diop H, Gupta M, Wachman EM. Impact of Coronavirus Disease-2019 on Hospital Care for Neonatal Opioid Withdrawal Syndrome. J Pediatr. 2022;245:47–55. doi: 10.1016/j.jpeds.2022.02.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Bruzelius E, Martins SS. US Trends in Drug Overdose Mortality Among Pregnant and Postpartum Persons, 2017-2020. JAMA. 2022;328(21):2159–2161.doi: 10.1001/jama.2022.17045 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES